Future Outlook of CAR T-Cell Therapy for DLBCL – OncLive
OncLive |
Future Outlook of CAR T-Cell Therapy for DLBCL
OncLive One is how to optimize CAR T-cell therapy, and this is happening now, by looking at the world-targeting of CAR T cells. So, the trend is to target CD19 and CD22, at least for B-cell malignancies. Because we learned that at least one mechanism of … |
